- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Snapshot for Perrigo Co (PRGO)
| Open: | 103.4600 | Day's Range: | 103.0700 - 104.6000 | Volume: | 513,226 | Bid: | 104.2100 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 103.0000 | 52wk Range: | 75.8910 - 108.6000 | 1-Yr Rtn: | +23.06% | Ask: | 104.2700 |
Stock Chart for PRGO
Key Statistics for PRGO
| Current P/E Ratio (ttm) | 24.0253 |
|---|---|
| Estimated P/E (06/2012) | 21.1030 |
| Earnings Per Share (USD) (ttm) | 4.3400 |
| Est. EPS (USD) (06/2012) | 4.9410 |
| Est. PEG Ratio | 1.9563 |
| Market Cap (M USD) | 9,754.14 |
| Shares Outstanding (M) | 93.55 |
| Enterprise Value (M USD) (ttm) | 10,696.29 |
| Enterprise Value/EBITDA (ttm) | 16.01 |
| Price/Book (mrq) | 5.4998 |
| Price/Sale (ttm) | 3.1855 |
| Dividend Indicated Gross Yield | 0.3069 |
| Next Earnings Announcement | 08/16/2012 |
More PRGO Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for PRGO
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for PRGO
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. The Company's primary markets and locations of manufacturing and logistics operations are the US, UK, Mexico, and Australia.
| Joseph C Papa "Joe"Chairman/President/CEO | Judy L BrownExec VP/CFO |
| Todd W KingmaExec VP/Secy/General Counsel | Scott F JamisonExec VP/Gen Mgr:Nutritionals |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page